XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting
3 Months Ended
Mar. 31, 2024
Segment Reporting  
Segment Reporting

14.  Segment Reporting

We report segment information based on the various industries in which our businesses operate and how we manage those businesses in accordance with our investment strategies, which may include: identifying and acquiring undervalued assets and businesses, often through the purchase of distressed securities; increasing value through management, financial or other operational changes; and managing complex legal, regulatory or financial issues, which may include bankruptcy or insolvency, environmental, zoning, permitting and licensing issues. Therefore, although many of our businesses are operated under separate local management, certain of our businesses are grouped together when they operate within a similar industry, comprising similarities in products, customers, production processes and regulatory environments, and when such businesses, when considered together, may be managed in accordance with one or more investment strategies specific to those businesses. Among other measures, we assess and measure segment operating results based on net income from continuing operations attributable to Icahn Enterprises. Certain terms of financings for certain of our businesses impose restrictions on the business’ ability to transfer funds to us, including restrictions on dividends, distributions, loans and other transactions.

Condensed Statements of Operations

Three Months Ended March 31, 2024

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

1,863

$

219

$

101

$

1

$

36

$

24

$

$

2,244

Other revenues from operations

 

 

 

165

 

 

17

 

 

1

 

 

183

Net loss from investment activities

 

(96)

 

 

 

 

 

 

 

 

(96)

Interest and dividend income

 

105

 

13

 

1

 

 

 

 

 

24

 

143

Loss on disposition of assets, net

 

 

(1)

 

(5)

 

 

 

 

 

 

(6)

 

9

 

1,875

 

380

 

101

 

18

 

36

 

25

 

24

 

2,468

Expenses:

Cost of goods sold

 

 

1,713

 

152

 

80

 

1

 

27

 

14

 

 

1,987

Other expenses from operations

 

 

 

139

 

 

14

 

 

 

 

153

Selling, general and administrative

 

4

 

42

 

102

 

13

 

5

 

10

 

10

 

7

 

193

Interest expense

 

25

 

33

 

 

3

 

 

 

 

75

 

136

Other loss (income), net

 

20

 

(4)

 

 

2

 

 

 

 

 

18

 

49

 

1,784

 

393

 

98

 

20

 

37

 

24

 

82

 

2,487

(Loss) income before income tax (expense) benefit

 

(40)

 

91

 

(13)

 

3

 

(2)

 

(1)

 

1

 

(58)

 

(19)

Income tax (expense) benefit

 

 

(13)

 

4

 

(1)

 

 

 

 

3

 

(7)

Net (loss) income

 

(40)

 

78

 

(9)

 

2

 

(2)

 

(1)

 

1

 

(55)

 

(26)

Less: net (loss) income attributable to non-controlling interests

 

(17)

 

29

 

 

 

 

 

 

 

12

Net (loss) income attributable to Icahn Enterprises

$

(23)

$

49

$

(9)

$

2

$

(2)

$

(1)

$

1

$

(55)

$

(38)

Supplemental information:

Capital expenditures

$

$

47

$

16

$

2

$

2

$

1

$

$

$

68

Depreciation and amortization

$

$

92

$

19

$

6

$

3

$

2

$

7

$

$

129

Three Months Ended March 31, 2023

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

 

Consolidated

(in millions)

 

Revenues:

    

  

  

  

  

  

  

  

  

 

  

Net sales

$

$

2,286

$

287

$

118

$

7

$

40

$

20

$

$

2,758

Other revenues from operations

 

 

 

170

 

 

16

 

 

1

 

 

187

Net loss from investment activities

 

(443)

 

 

 

 

 

 

 

 

(443)

Interest and dividend income

 

144

 

5

 

 

 

 

 

 

22

 

171

 

(299)

 

2,291

 

457

 

118

 

23

 

40

 

21

 

22

 

2,673

Expenses:

 

Cost of goods sold

 

 

1,926

 

193

 

91

 

6

 

32

 

12

 

 

2,260

Other expenses from operations

 

 

 

145

 

 

13

 

 

 

 

158

Selling, general and administrative

 

3

 

46

 

132

 

14

 

4

 

10

 

13

 

7

 

229

Loss on deconsolidation of subsidiary

 

226

226

Interest expense

 

45

 

23

 

 

3

 

 

 

 

71

 

142

Other loss (income), net

 

28

 

(3)

 

 

7

 

 

 

 

 

32

 

76

 

1,992

 

470

 

115

 

23

 

42

 

25

 

304

 

3,047

(Loss) income before income tax (expense) benefit

 

(375)

 

299

 

(13)

 

3

 

 

(2)

 

(4)

 

(282)

 

(374)

Income tax (expense) benefit

 

 

(52)

 

 

4

 

 

 

 

64

 

16

Net (loss) income

 

(375)

 

247

 

(13)

 

7

 

 

(2)

 

(4)

 

(218)

 

(358)

Less: net (loss) income attributable to non-controlling interests

 

(204)

 

115

 

 

1

 

 

 

 

 

(88)

Net (loss) income attributable to Icahn Enterprises

$

(171)

$

132

$

(13)

$

6

$

$

(2)

$

(4)

$

(218)

$

(270)

Supplemental information:

 

Capital expenditures

$

$

44

$

10

$

2

$

2

$

$

$

$

58

Depreciation and amortization

$

$

84

$

19

$

7

$

3

$

2

$

7

$

$

122

Disaggregation of Revenue

In addition to the condensed statements of operations by reporting segment above, we provide additional disaggregated revenue information for our Energy and Automotive segments below.

Energy

Three Months Ended March 31, 

    

2024

    

2023

Petroleum products

$

1,735

$

2,060

Nitrogen fertilizer products

 

128

 

226

$

1,863

$

2,286

Automotive

Three Months Ended March 31, 

    

2024

    

2023

Automotive Services

$

356

$

369

Aftermarket Parts

 

13

 

72

Total revenue from customers

369

441

Lease revenue outside the scope of ASC 606

15

16

Total Automotive net sales and other revenues from operations

$

384

$

457

Condensed Balance Sheets

March 31, 2024

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

6

$

644

$

64

$

7

$

33

$

4

$

18

$

1,692

$

2,468

Cash held at consolidated affiliated partnerships and restricted cash

 

2,379

 

 

8

 

 

4

 

3

 

 

171

 

2,565

Investments

 

3,203

 

98

 

 

 

14

 

 

 

 

3,315

Accounts receivable, net

 

 

253

 

41

 

85

 

16

 

22

 

30

 

 

447

Inventories, net

 

 

601

 

213

 

118

 

 

85

 

22

 

 

1,039

Related party notes receivable, net

11

11

Property, plant and equipment, net

 

 

2,572

 

822

 

129

 

363

 

50

 

 

4

 

3,940

Goodwill and intangible assets, net

 

 

174

 

333

 

23

 

 

19

 

191

 

 

740

Other assets

 

4,352

 

287

 

477

 

98

 

71

 

20

 

7

 

227

 

5,539

Total assets

$

9,940

$

4,629

$

1,958

$

460

$

501

$

203

$

268

$

2,105

$

20,064

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

999

$

1,506

$

840

$

136

$

55

$

44

$

54

$

553

$

4,187

Securities sold, not yet purchased, at fair value

 

3,644

 

 

 

 

 

 

 

 

3,644

Debt

 

 

1,585

 

29

 

138

 

1

 

8

 

 

4,847

 

6,608

Total liabilities

 

4,643

 

3,091

 

869

 

274

 

56

 

52

 

54

 

5,400

 

14,439

Equity attributable to Icahn Enterprises

 

3,202

 

811

 

1,089

 

169

 

440

 

151

 

214

 

(3,295)

 

2,781

Equity attributable to non-controlling interests

 

2,095

 

727

 

 

17

 

5

 

 

 

 

2,844

Total equity

 

5,297

 

1,538

 

1,089

 

186

 

445

 

151

 

214

 

(3,295)

 

5,625

Total liabilities and equity

$

9,940

$

4,629

$

1,958

$

460

$

501

$

203

$

268

$

2,105

$

20,064

December 31, 2023

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

23

$

1,179

$

104

$

8

$

22

$

5

$

26

$

1,584

$

2,951

Cash held at consolidated affiliated partnerships and restricted cash

 

2,799

 

7

 

9

 

 

4

 

3

 

 

173

 

2,995

Investments

 

2,898

 

100

 

 

 

14

 

 

 

 

3,012

Accounts receivable, net

 

 

286

 

41

 

89

 

16

 

26

 

27

 

 

485

Related party note receivable, net

11

11

Inventories, net

 

 

604

 

228

 

111

 

 

81

 

23

 

 

1,047

Property, plant and equipment, net

 

 

2,594

 

822

 

134

 

363

 

52

 

 

4

 

3,969

Goodwill and intangible assets, net

 

 

179

 

335

 

23

 

 

19

 

198

 

 

754

Other assets

 

4,425

 

310

 

480

 

101

 

69

 

17

 

8

 

224

 

5,634

Total assets

$

10,145

$

5,259

$

2,019

$

466

$

488

$

203

$

282

$

1,996

$

20,858

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

1,312

$

1,553

$

890

$

148

$

43

$

42

$

55

$

62

$

4,105

Securities sold, not yet purchased, at fair value

 

3,473

 

 

 

 

 

 

 

 

3,473

Debt

 

 

2,185

 

33

 

133

 

1

 

8

 

 

4,847

 

7,207

Total liabilities

 

4,785

 

3,738

 

923

 

281

 

44

 

50

 

55

 

4,909

 

14,785

Equity attributable to Icahn Enterprises

 

3,243

 

795

 

1,096

 

168

 

439

 

153

 

227

 

(2,913)

 

3,208

Equity attributable to non-controlling interests

 

2,117

 

726

 

 

17

 

5

 

 

 

 

2,865

Total equity

 

5,360

 

1,521

 

1,096

 

185

 

444

 

153

 

227

 

(2,913)

 

6,073

Total liabilities and equity

$

10,145

$

5,259

$

2,019

$

466

$

488

$

203

$

282

$

1,996

$

20,858